Endocannabinoid signaling at the periphery: 50 years after THC
2015 · Trends in Pharmacological Sciences · 632 citations
https://doi.org/10.1016/j.tips.2015.02.008
R
Raphael Mechoulam
Hebrew College(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
563
Papers
51.9K
Citations
116
h-index
372
i10-index
Raphael Mechoulam is an academic researcher from Hebrew College. The author has contributed to research in topics: Cannabis and Cannabinoid Research & Neuroscience and Neuropharmacology Research & Neurotransmitter Receptor Influence on Behavior. The author has an h-index of 116, co-authored 479 publications.
ORCID: 0000-0002-6122-5698Papers by this author
worksReal life Experience of Medical Cannabis Treatment in Autism: Analysis of Safety and Efficacy
2019 · Scientific Reports · 172 citations
https://doi.org/10.1038/s41598-018-37570-y
Cannabidiol attenuates alcohol-induced liver steatosis, metabolic dysregulation, inflammation and neutrophil-mediated injury
2017 · Scientific Reports · 120 citations
https://doi.org/10.1038/s41598-017-10924-8
Effect of the synthetic cannabinoid HU-210 on quorum sensing and on the production of quorum sensing-mediated virulence factors by Vibrio harveyi
2015 · BMC Microbiology · 30 citations
https://doi.org/10.1186/s12866-015-0499-0
Anandamide alters the membrane properties, halts the cell division and prevents drug efflux in multidrug resistant Staphylococcus aureus
2021 · Scientific Reports · 27 citations
https://doi.org/10.1038/s41598-021-88099-6
Anandamide prevents the adhesion of filamentous Candida albicans to cervical epithelial cells
2020 · Scientific Reports · 21 citations
https://doi.org/10.1038/s41598-020-70650-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat